Cite
HARVARD Citation
Derlin, T. et al. (2018). [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer. Lancet oncology. 19 (8), pp. e372-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Derlin, T. et al. (2018). [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer. Lancet oncology. 19 (8), pp. e372-. [Online].